All Stories

  1. Levocetirizine Pretreatment Mitigates Lipopolysaccharide-Induced Lung Inflammation in Rats

    Article • BioMed Research International, August 2018, Hindawi Publishing Corporation

    Dr George Shehatou

  2. Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, December 2015, Springer Science + Business Media

    Dr George Shehatou

  3. Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits

    Article • Experimental Biology and Medicine, October 2015, SAGE Publications

    Dr George Shehatou

  4. Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats

    Article • European Journal of Pharmacology, October 2014, Elsevier

    Dr George Shehatou

  5. Long-Term Channel Block Is Required to Inhibit Cellular Transformation by Human Ether-à-Go-Go–Related Gene (hERG1) Potassium Channels

    Article • Molecular Pharmacology, May 2014, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr George Shehatou